Yijun Wang

1.4k total citations · 1 hit paper
32 papers, 894 citations indexed

About

Yijun Wang is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Yijun Wang has authored 32 papers receiving a total of 894 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 12 papers in Cancer Research and 6 papers in Oncology. Recurrent topics in Yijun Wang's work include RNA modifications and cancer (6 papers), Fibroblast Growth Factor Research (5 papers) and Cancer, Hypoxia, and Metabolism (5 papers). Yijun Wang is often cited by papers focused on RNA modifications and cancer (6 papers), Fibroblast Growth Factor Research (5 papers) and Cancer, Hypoxia, and Metabolism (5 papers). Yijun Wang collaborates with scholars based in China and South Korea. Yijun Wang's co-authors include Limin Xia, Tongyue Zhang, Danfei Liu, Wenjie Huang, Mengyu Sun, Xiaoyu Ji, Bixiang Zhang, Meng Xie, Xiangyuan Luo and Yangyang Feng and has published in prestigious journals such as SHILAP Revista de lepidopterología, Hepatology and Oncogene.

In The Last Decade

Yijun Wang

32 papers receiving 889 citations

Hit Papers

FGF19/FGFR4-mediated elev... 2023 2026 2024 2023 25 50 75 100

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yijun Wang China 17 509 295 223 186 131 32 894
Ho Lam Chan United States 14 674 1.3× 222 0.8× 406 1.8× 158 0.8× 240 1.8× 20 1.2k
Daya Luo China 15 513 1.0× 318 1.1× 225 1.0× 137 0.7× 112 0.9× 48 907
Nobuyuki Nishizawa Japan 20 437 0.9× 169 0.6× 233 1.0× 118 0.6× 151 1.2× 50 853
Dai Liu China 15 366 0.7× 174 0.6× 170 0.8× 199 1.1× 46 0.4× 37 723
Xianglin Yuan China 13 283 0.6× 195 0.7× 271 1.2× 118 0.6× 120 0.9× 32 691
Xiaolin Lin China 20 599 1.2× 368 1.2× 147 0.7× 145 0.8× 44 0.3× 45 1000
Haiyan Zhang China 15 411 0.8× 210 0.7× 173 0.8× 176 0.9× 87 0.7× 24 879
Tao Ma China 11 434 0.9× 197 0.7× 206 0.9× 85 0.5× 75 0.6× 46 787
Shanhua Tang China 7 907 1.8× 747 2.5× 196 0.9× 141 0.8× 90 0.7× 11 1.2k

Countries citing papers authored by Yijun Wang

Since Specialization
Citations

This map shows the geographic impact of Yijun Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yijun Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yijun Wang more than expected).

Fields of papers citing papers by Yijun Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yijun Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yijun Wang. The network helps show where Yijun Wang may publish in the future.

Co-authorship network of co-authors of Yijun Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Yijun Wang. A scholar is included among the top collaborators of Yijun Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yijun Wang. Yijun Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Jie, Bin Zhang, Zhiyuan Zhou, et al.. (2024). Stabilization of KPNB1 by deubiquitinase USP7 promotes glioblastoma progression through the YBX1-NLGN3 axis. Journal of Experimental & Clinical Cancer Research. 43(1). 28–28. 11 indexed citations
2.
Jiang, Junqing, Yufei Wang, Mengyu Sun, et al.. (2024). SOX on tumors, a comfort or a constraint?. Cell Death Discovery. 10(1). 67–67. 8 indexed citations
3.
Zhang, Zerui, Yijun Wang, Siwen Li, et al.. (2024). Transcription factor ELF4 in physiology and diseases: Molecular roles and clinical implications. Genes & Diseases. 12(3). 101394–101394. 2 indexed citations
4.
Xie, Meng, Zhuoying Lin, Xiaoyu Ji, et al.. (2023). FGF19/FGFR4-mediated elevation of ETV4 facilitates hepatocellular carcinoma metastasis by upregulating PD-L1 and CCL2. Journal of Hepatology. 79(1). 109–125. 112 indexed citations breakdown →
5.
Hu, Yan, Chao Wan, Yang Xiao, et al.. (2023). Radiated tumor cell-derived microparticles effectively kill stem-like tumor cells by increasing reactive oxygen species. Frontiers in Bioengineering and Biotechnology. 11. 1156951–1156951. 2 indexed citations
6.
Chen, Jie, Weibo Feng, Wenjie Huang, et al.. (2023). FGF19-mediated ELF4 overexpression promotes colorectal cancer metastasis through transactivating FGFR4 and SRC. Theranostics. 13(4). 1401–1418. 19 indexed citations
7.
Ji, Xiaoyu, Xiaoping Chen, Bixiang Zhang, et al.. (2022). T-box transcription factor 19 promotes hepatocellular carcinoma metastasis through upregulating EGFR and RAC1. Oncogene. 41(15). 2225–2238. 15 indexed citations
9.
He, Qin, Wenjie Huang, Danfei Liu, et al.. (2021). Homeobox B5 promotes metastasis and poor prognosis in Hepatocellular Carcinoma, via FGFR4 and CXCL1 upregulation. Theranostics. 11(12). 5759–5777. 30 indexed citations
10.
Sun, Mengyu, Meng Xie, Tongyue Zhang, et al.. (2021). m6A Methylation Modification Patterns and Tumor Microenvironment Infiltration Characterization in Pancreatic Cancer. Frontiers in Immunology. 12. 739768–739768. 12 indexed citations
11.
Lin, Zhuoying, Wenjie Huang, Qin He, et al.. (2021). FOXC1 promotes HCC proliferation and metastasis by Upregulating DNMT3B to induce DNA Hypermethylation of CTH promoter. Journal of Experimental & Clinical Cancer Research. 40(1). 50–50. 51 indexed citations
12.
Qiao, Chenyang, Wenjie Huang, Jie Chen, et al.. (2021). IGF1-mediated HOXA13 overexpression promotes colorectal cancer metastasis through upregulating ACLY and IGF1R. Cell Death and Disease. 12(6). 564–564. 46 indexed citations
13.
Zhang, Tongyue, Danfei Liu, Yijun Wang, Mengyu Sun, & Limin Xia. (2021). The E-Twenty-Six Family in Hepatocellular Carcinoma: Moving into the Spotlight. Frontiers in Oncology. 10. 620352–620352. 2 indexed citations
14.
Liu, Danfei, Tongyue Zhang, Xiaoping Chen, et al.. (2021). ONECUT2 facilitates hepatocellular carcinoma metastasis by transcriptionally upregulating FGF2 and ACLY. Cell Death and Disease. 12(12). 1113–1113. 39 indexed citations
15.
Jia, Youchao, Wei He, Hu Zhang, et al.. (2020). Morusin Ameliorates IL-1β-Induced Chondrocyte Inflammation and Osteoarthritis via NF-κB Signal Pathway. SHILAP Revista de lepidopterología. 4 indexed citations
16.
Chen, Jie, Yunzhi Dang, Weibo Feng, et al.. (2020). SOX18 promotes gastric cancer metastasis through transactivating MCAM and CCL7. Oncogene. 39(33). 5536–5552. 30 indexed citations
17.
Liu, Danfei, Tongyue Zhang, Yijun Wang, & Limin Xia. (2020). Tocilizumab: The Key to Stop Coronavirus Disease 2019 (COVID-19)-Induced Cytokine Release Syndrome (CRS)?. Frontiers in Medicine. 7. 571597–571597. 11 indexed citations
18.
Wang, Yijun, et al.. (2020). circCRKL suppresses the progression of prostate cancer cells by regulating the miR-141/KLF5 axis. Pathology - Research and Practice. 216(11). 153182–153182. 16 indexed citations
19.
Zhou, Yongjie, Zezhi Li, Yijun Wang, et al.. (2019). Prevalence and clinical correlates of psychotic depression in first-episode and drug-naïve outpatients with major depressive disorder in a Chinese Han population. Journal of Affective Disorders. 263. 500–506. 32 indexed citations
20.
Liu, Jiao, Yingtang Gao, Bin Yang, et al.. (2015). Overexpression of Squamous Cell Carcinoma Antigen 1 Is Associated with the Onset and Progression of Human Hepatocellular Carcinoma. Archives of Medical Research. 46(2). 133–141. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026